PRO DEX INC (NASDAQ:PDEX) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 06, 2026.
At publication ·
PRO DEX INC (NASDAQ:PDEX) · proxy filed
At a glance
PRO DEX INC (NASDAQ:PDEX) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on October 06, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
PRO DEX INC's stock currently trades at $64.92 with a market capitalization of $142.9M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing PRO DEX INC's filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for PRO DEX INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PDEX Stock Page
Browse all filings on our PDEX SEC filings page.
Public companies like PRO DEX INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · PDEX
Keep reading
